- Home
- RNG vs APGE Comparison
RNG vs APGE Comparison
Compare RNG & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNG
- APGE
- Stock Information
- Founded
- RNG 1999
- APGE 2022
- Country
- RNG United States
- APGE United States
- Employees
- RNG N/A
- APGE N/A
- Industry
- RNG EDP Services
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RNG Technology
- APGE Health Care
- Exchange
- RNG Nasdaq
- APGE Nasdaq
- Market Cap
- RNG 2.3B
- APGE 2.6B
- IPO Year
- RNG 2013
- APGE 2023
- Fundamental
- Price
- RNG $27.67
- APGE $38.14
- Analyst Decision
- RNG Buy
- APGE Strong Buy
- Analyst Count
- RNG 15
- APGE 4
- Target Price
- RNG $34.00
- APGE $97.50
- AVG Volume (30 Days)
- RNG 1.4M
- APGE 1.3M
- Earning Date
- RNG 07-31-2025
- APGE 08-11-2025
- Dividend Yield
- RNG N/A
- APGE N/A
- EPS Growth
- RNG N/A
- APGE N/A
- EPS
- RNG N/A
- APGE N/A
- Revenue
- RNG $2,428,240,000.00
- APGE N/A
- Revenue This Year
- RNG $5.82
- APGE N/A
- Revenue Next Year
- RNG $5.51
- APGE $743.14
- P/E Ratio
- RNG N/A
- APGE N/A
- Revenue Growth
- RNG 7.78
- APGE N/A
- 52 Week Low
- RNG $20.59
- APGE $26.20
- 52 Week High
- RNG $42.19
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- RNG 48.08
- APGE 43.45
- Support Level
- RNG $29.41
- APGE $36.40
- Resistance Level
- RNG $30.22
- APGE $39.33
- Average True Range (ATR)
- RNG 0.85
- APGE 3.04
- MACD
- RNG -0.03
- APGE -0.83
- Stochastic Oscillator
- RNG 35.15
- APGE 20.25
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.